Chronic mild hyperhomocysteinemia induces anxiety-like symptoms, aversive memory deficits and hippocampus atrophy in adult rats: New insights into physiopathological mechanisms

• Published in: Brain research Vol. 1728; p. 146592
• Main Authors: Wyse, A.T.S., Sanches, E.F., Dos Santos, T.M., Siebert, C., Kolling, J., Netto, C.A.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01-02-2020
• Subjects: Adenosine Triphosphate - metabolism; Animals; Anxiety - etiology; Anxiety - pathology; Atrophy - etiology; Atrophy - pathology; Avoidance Learning; Behavior; Chronic Disease; DNA damage; DNA Damage - physiology; Electron Transport Complex IV - metabolism; Hippocampal atrophy; Hippocampus - pathology; Hippocampus - physiopathology; Homocysteine; Homocysteine - blood; Hyperhomocysteinemia - chemically induced; Hyperhomocysteinemia - complications; Long-term aversive memory; Male; Memory Disorders - etiology; Memory Disorders - physiopathology; Mild hyperhomocisteinemia; Open Field Test; Oxidative Stress - physiology; Rats; Rats, Wistar; Mild hyperhomocisteinemia; Behavior; Homocysteine; Long-term aversive memory; DNA damage; Hippocampal atrophy
• ISSN: 0006-8993; 1872-6240
• DOI: 10.1016/j.brainres.2019.146592

•Increased levels of homocysteine are a marker for neurodegeneration.•Hcy caused anxiety-like behavior, long-term aversive memory deficits and hippocampal atrophy.•Molecular mechanisms involve oxidative stress and DNA damage in the hippocampus.
In the last decade, increased homocysteine levels have been implicated as a risk factor for neurodegenerative and psychiatric disorders. We have developed an experimental model of chronic mild hyperhomocysteinemia (HHcy) in order to observe metabolic impairments in the brain of adult rodents. Besides its known effects on brain metabolism, the present study sought to investigate whether chronic mild HHcy could induce learning/memory impairments associated with biochemical and histological damage to the hippocampus. Adult male Wistar rats received daily subcutaneous injections of homocysteine (0.03 μmol/g of body weight) twice a day, from the 30th to the 60th day of life or saline solution (Controls). After injections, anxiety-like and memory tests were performed. Following behavioral analyses, brains were sliced and hippocampal volumes assessed and homogenized for redox state assessment, antioxidant activity, mitochondrial functioning (chain respiratory enzymes and ATP levels) and DNA damage analyses. Behavioral analyses showed that chronic mild HHcy may induce anxiety-like behavior and impair long-term aversive memory (24 h) that was evaluated by inhibitory avoidance task. Mild HHcy decreased locomotor and/or exploratory activities in elevated plus maze test and caused hippocampal atrophy. Decrease in cytochrome c oxidase, DNA damage and redox state changes were also observed in hippocampus of adult rats subjected to mild HHcy. Our findings show that chronic mild HHcy alters biochemical and histological parameters in the hippocampus, leading to behavioral impairments. These findings might be considered in future studies aiming to search for alternative strategies for treating the behavioral impairments in patients with mild elevations in homocysteine levels.